Arsenic trioxide, a therapeutic agent for APLZHANG, Ting-Dong; CHEN, Guo-Qiang; WANG, Zhu-Gang et al.Oncogene (Basingstoke). 2001, Vol 20, Num 49, pp 7146-7153, issn 0950-9232Article

Arsenic trioxide: expanding roles for an ancient drug?RAVANDI, F.Leukemia. 2004, Vol 18, Num 9, pp 1457-1459, issn 0887-6924, 3 p.Article

Metabolism and excretion of orally administrated arsenic trioxide in the hamsterYAMAUCHI, H; YAMAMURA, Y.Toxicology (Amsterdam). 1985, Vol 34, Num 2, pp 113-121, issn 0300-483XArticle

MODIFICATIONS DANS L'ACTIVITE DES DESHYDROGENASES DES ORGANES INTERNES DE RATS BLANCS PENDANT L'INTOXICATION PAR DES COMPOSES DE L'ARSENIC ET DU PLOMB1972; KHIG. I ZDRAVEOPAZV.; BALG.; DA. 1972; VOL. 15; NO 1; PP. 38-46; ABS. ANGL.; BIBL. 22 REF.Serial Issue

LEARNING RETARDATION IN ADULT RATS APPLIED ARSENIC TRIOXIDE FROM BIRTH TO WEANINGKIYONO S; TAMAKI Y; SEO M et al.1975; J. PHYSIOL. SOC. JAP.; JAP.; DA. 1975; VOL. 37; NO 2; PP. 31-32; BIBL. 3REF.Article

SLEEP-WAKEFULNESS CYCLE IN ADULT RATS APPLIED ARSENIC TRIOXIDE FROM BIRTH TO WEANINGKIYONO S; HASUI K; TAKASU K et al.1974; J. PHYSIOL. SOC. JAP.; JAP.; DA. 1974; VOL. 36; NO 6; PP. 233-234; BIBL. 8REF.Article

TOXIC EFFECT OF ARSENIC TRIOXIDE IN INFANT RATSKIYONO S; HASUI K; TAKASU K et al.1974; J. PHYSIOL. SOC. JAP.; JAP.; DA. 1974; VOL. 36; NO 7; PP. 253-254; ABS. ANGL.; BIBL. 5REF.Article

Expanding the use of arsenic trioxide: Leukemias and beyondZHU CHEN; CHEN, Guo-Qiang; SHEN, Zhi-Xiang et al.Seminars in hematology. 2002, Vol 39, Num 2, pp 22-26, issn 0037-1963, SUP1Article

Arsenic trioxide as a selective anticancer agent: rationale and clinical utilityTALLMAN, Martin S.Seminars in hematology. 2002, Vol 39, Num 2, issn 0037-1963, 27 p., SUP1Serial Issue

Mise au point d'une méthode de prélèvement du trioxyde de diarsenic = Development of a method for sampling arsenic trioxydeDEMANGE, M; VIEN, I; HECHT, G et al.Les Cahiers de notes documentaires - Institut national de sécurité. 1992, Num 146, pp 63-70, issn 0007-9952Article

Cardiac monitoring of patients receiving arsenic trioxide therapyUNNIKRISHNAN, Dilip; DUTCHER, Janice P; GARL, Susan et al.British journal of haematology. 2004, Vol 124, Num 5, pp 610-617, issn 0007-1048, 8 p.Article

Cinétique de séchage du trioxyde d'arsenicEFREMOV, A. A; GRINBERG, E. E; DIOGIDZE, O. SH et al.Himičeskaja promyšlennost. 1984, Num 4, pp 228-229Article

Suppression by arsenic trioxide of the induction of mutations in the mouse bone-marrow and male germ cells by an alkylating agentPASCHIN, Y. V; KOZACHENKO, V. I; TOROPZEV, S. N et al.International journal of environmental studies. 1983, Vol 21, Num 3-4, pp 317-324, issn 0020-7233Article

SOLUBILITE DU TRIOXYDE DE AS DANS DES SOLUTIONS AQUEUSES, A PH 0,3-13,3AZERBAEVA RG; ADISHCHEVA NP; GLADYSHEV VP et al.1978; ZH. NEORG. KHIM.; SUN; DA. 1978; VOL. 23; NO 9; PP. 2570-2572; BIBL. 8 REF.Article

MOLECULAR SPECIES IN THE AS-O SYSTEMBRITTAIN RD; LAU KH; HILDENBRAND DL et al.1982; J. PHYS. CHEM.; ISSN 0022-3654; USA; DA. 1982; VOL. 86; NO 26; PP. 5072-5075; BIBL. 15 REF.Article

Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in guinea pigSUN, Hong-Li; CHU, Wen-Feng; DONG, De-Li et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 98, Num 4, pp 381-388, issn 1742-7835, 8 p.Article

Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromesSCHILLER, Gary J; SLACK, James; HAINSWORTH, John D et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2456-2464, issn 0732-183X, 9 p.Article

Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapyDOMBRET, Hervé; FENAUX, Pierre; SOIGNET, Steven L et al.Seminars in hematology. 2002, Vol 39, Num 2, pp 8-13, issn 0037-1963, SUP1Article

Modulation de l'apoptose: un enjeu thérapeutique pour demain : exemple du trioxyde d'arsenic, un espoir pour le traitement de la leucémie aiguë promyélocytaire = Modulation of apoptosis : a therapeutic objective for the future : arsenic trioxide, a progress to treat the acute promyelocytic leukemiaHOURI, J.-J; ACAR, V; PRADEAU, D et al.Journal de pharmacie clinique (Paris). 2000, Vol 19, Num 2, pp 108-114, issn 0291-1981Article

Etude pharmacocinétique comparative de l'anhydrine arsenieux chez le rat et la souris = Comparison of the pharmacokinetics of arsenic trioxide in the rat and the mouseBRUNET, C; LUYCKX, M; CAZIN, M et al.Journal de toxicologie médicale. 1984, Vol 4, Num 4, pp 293-303, issn 0249-6216Article

Arsenic trioxide in patients with myelodysplastic syndromes : A phase II multicenter studyVEY, Norbert; BOSLY, Andre; CASADEVALL, Nicole et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2465-2471, issn 0732-183X, 7 p.Article

Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signalingJING YI; JIE YANG; RONG HE et al.Cancer research (Baltimore). 2004, Vol 64, Num 1, pp 108-116, issn 0008-5472, 9 p.Article

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARα catabolism, role of oncogene degradation in disease remissionJUN ZHU; LALLEMAND-BREITENBACH, Valérie; DE THE, Hugues et al.Oncogene (Basingstoke). 2001, Vol 20, Num 49, pp 7257-7265, issn 0950-9232Article

Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workersVAHTER, M; FRIBERG, L; RAHNSTER, B et al.International archives of occupational and environmental health. 1986, Vol 57, Num 2, pp 79-91, issn 0340-0131Article

Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agentsYU, Zu-Yin; LIANG, Yu-Guang; WANG, Sheng-Qi et al.International journal of cancer. 2007, Vol 121, Num 9, pp 2084-2094, issn 0020-7136, 11 p.Article